baber/WOPTO huggingface dataset:
Patent AU-2890297-A (AU)
Title: The use of a genetic modification in the gene for human G protein beta3 subunit for the diagnosis of diseases
Inventor: SIFFERT WINFRIED
IPC: C12Q1/68
Filed: 1997-05-02
Abstract: A method of diagnosing a disease comprising determining the presence of a genetic modification in a gene obtained from a subject which encodes a human G protein beta3 subunit. Also disclosed is a method for establishing the relative risk of developing a disorder associated with G protein dysregulation.
Patent AU-2991600-A (AU)
Title: Method of making a conductive downhole wire line system
Inventor: MOORE BOYD B
IPC: E21B19/08
Filed: 2000-02-11
Abstract: A method for inserting at least one conductor into an elongated length of metal coiled tubing, includes the steps of placing the coiled tubing in a substantially vertical passageway, inserting the conductor into the tubing, the leading end of the conductor including an elongated weight connected to the conductor, which weight is heavy enough to straighten the conductor enough to fall through the tubing, the weight having essentially no stiffness so that it is flexible enough to move through bends or irregularities in the tubing, allowing the conductor and weight to fall by gravity through the tubing, which has a sufficient helical pitch providing a hold-up force due to friction for preventing the conductors from breaking, until the desired length of conductor is inserted in the tubing, and removing the tubing with the conductor inside the tubing from the passageway and winding the tubing on a reel.
Patent AU-3027289-A (AU)
Title: 4-substituted imidazole derivatives useful in perioperative care
Inventor: MAZE MERVYN
IPC: A61K31/415
Filed: 1989-02-23
Abstract: 4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, known as medetomidine, and in particular its d-enantiomer and salts thereof are useful in perioperative care, in particular in reducing the amount of anaesthetic it is necessary to administer.
Patent AU-3074300-A (AU)
Title: Process for producing hmg-coa reductase inhibitors
Inventor: HASHIMOTO SHINICHI
IPC: C12P17/06
Filed: 2000-01-20
Abstract: The present invention relates to a process for producing a compound (II-a) or a compound (II-b), each of which is a hydroxylated product of a compound represented by the formula (I-a) (hereinafter referred to as compound (I-a)): <CHEM>  wherein   R<1> represents a hydrogen atom, a substituted or unsubstituted alkyl, or an alkali metal, and R<2> represents a substituted or unsubstituted alkyl, or a substituted or unsubstituted aryl; or a ring-closed lactone form thereof (hereinafter referred to as compound (I-b)).  wherein the process comprises:   treating the compound (I-a) or compound (I-b) in an aqueous medium comprising with a microorganism acting to hydroxylate compound (I-a) or compound (I-b), having no ability to sporulate and showing no hyphal growth, a culture of the microorganism, or a   treated product of the culture, as an enzyme source ; and collecting a hydroxylated product of compound (I-a) or compound (I-b) from the aqueous medium.
Patent AU-3122795-A (AU)
Title: Nematicidic agent and method for the bio-control of nematodes
Inventor: CAMPOS JESUS MENA
IPC: A01N63/20
Filed: 1995-08-10
Abstract: A method for obtaining a bacterial strain having nematicidal properties comprises collecting samples of soil and/or plant tissues from an area affected by nematodes, distinguishing samples of highly affected material from samples of less affected material, isolating bacterial strains present in said samples, comparing bacterial strains present in highly affected samples with strains present in less affected samples, selecting strains present only in the less affected samples, testing nematicidal properties of the selected strains and selecting those bacterial strains having useful nematicidal properties. A method for the biocontrol of nematodes comprises contacting the soil, a plant or a seed with an effective quantity of a nematicidal agent which is a culture obtained from Sphingo bacterium spiritivorum C-926 and/or Corynobacterium pauro metabolum C-924, or a metabolite derived from the said strain, obtained by natural, recombinant or synthetic route, in an appropriate carrier, or using the said nematicidal agent in a veterinary compsn. for the control of 300 nematodes. The said cultures, used as nematodicidic agent in this method, or any mutation derived from them which is active against nematodes, are also claimed, as are nematicidic agents comprising the said agents and an appropriate carrier.
Patent AU-3298893-A (AU)
Title: The cd40cr receptor and ligands therefor
IPC: A61P37/08
Filed: 1993-02-12
Abstract: The present invention relates to an antibody that binds an antigen that: 
(a) is present on activated but not resting helper T-cells; 
(b) has the same molecular weight as a protein precipitated by a CD40-immunoglobulin (CD40-Ig) fusion protein, the CD40-Ig comprising the extracellular domain of a CD40 protein having the amino acid sequence of SEQ ID NO:2 and an extracellular domain at the site of fusion having the amino acid sequence of SEQ ID NO:3; and 
(c) is pre-cleared by precipitation with the CD40-Ig; 
wherein the antibody is capable of blocking binding of the CD40-Ig to activated helper T-cells and is capable of inhibiting helper T-cell induction of B-cell activation.  The present invention also relates to pharmaceutical compositions comprising said antibody and the use of said antibody for therapeutic purposes, e. g. for inhibiting immunoglobulin production, inhibiting activation of B-cells and for treating disorders associated with B-cell activation, allergy, e. g.-anaphylaxis, autoimmune conditions, e. g. drug-induced lupus, systemic lupus erythematosus, adult rheumatoid arthritis, juvenile rheumatoid arthritis, scleroderma or Sjogren's syndrome, or viral diseases that involve B-cells, e. g. Epstein-Barr infection or retroviral infections such as infections with the human immunodeficiency virus.
Patent AU-3364893-A (AU)
Title: Laminated films
Inventor: RASMUSSEN OLE-BENDT
IPC: B29C49/00
Filed: 1993-01-28
Abstract: PCT No. PCT/GB93/00177 Sec. 371 Date Jun. 16, 1994 Sec. 102(e) Date Jun. 16, 1994 PCT Filed Jan. 28, 1993 PCT Pub. No. WO93/14928 PCT Pub. Date Aug. 5, 1993A cross-laminate of two or more individually stretch oriented films where the directions of orientation of the films are in criss-crossing relation, has a pattern of generally parallel elongated ribs extending lengthwise of the laminate. The ribs are defined between generally transversely coincident convex and concave curved surfaces on opposite faces of the laminate, the concave surface having a radius of curvature greater than that of the convex surface so that the ribs have a thickness greater than the average thickness of the laminate. The laminate material adjacent to lateral boundaries of the ribs is in a tensionless state reversely curved relative to the rib curvature making the material between adjacent pairs of ribs generally flat. The rib pattern is preferably regular with a preferred average transverse spacing between adjacent ribs, measured peak to peak, of about 1-10 mm. The convex surfaces of the ribs can all be on the same side of the laminate or can alternate in series between opposite sides. The pattern of elongated ribs can be interrupted at longitudinally spaced loci to enhance the flexibility of the laminate and the laminate can have an undulating curvature when viewed from the side. A process and apparatus for making the ribbed cross-laminate by means of intermeshing grooved rollers are also disclosed.
Patent AU-3406489-A (AU)
Title: Use of and agent for reducing side effects of tnf
Inventor: HEUER HUBERT
IPC: A61K38/19
Filed: 1989-05-05
Abstract: Concomitant administration of TNFs with a PAF antagonist allows the unwanted side effects of the TNFs to be reduced and the therapeutic index of the TNFs to be increased.
Patent AU-3781597-A (AU)
Title: Cationic lipid-nucleic acid complexes
Inventor: BISCHOFF RAINER
IPC: A61K9/127
Filed: 1997-08-25
Abstract: The invention is related to a method for preparing an homogenous suspension of stable lipid-nucleic acid complexes or particles, comprising: a) combining one or more cationic lipids, one or more colipids, and one or more stabilizing additives to form a lipid suspension, b) combining the lipid suspension with a nucleic acid to form a complex or a particle, and optionally c) subjecting the complex or particle to a sizing procedure. It also concerns an homogenous suspension produced notably by the above method.
Patent AU-3883100-A (AU)
Title: Hearing protective device
Inventor: FALCO ROBERT N
IPC: A61F11/10
Filed: 2000-03-14
Abstract: An acoustical hearing device is presented, comprising a foam and at least one component which is mechanically bonded to the foam. The mechanical bonding of the component arises during manufacture, wherein the component is placed into a mold cavity as an insert and a foam is formed within the mold so as to allow controlled penetration of the component during foaming. In an exemplary embodiment, the at least one component comprises a stem having a tip at one end, wherein the tip includes at least one opening at least partially extending therethrough. The mechanical bond resulting when the foam extends through the at least one opening.
Patent AU-3915200-A (AU)
Title: High frequency switch-mode dc powered computer system
Inventor: PORTER ROBERT M
IPC: H02J1/00
Filed: 2000-03-23
Abstract: Method and apparatus are disclosed for providing a constant voltage, high frequency sinusoidal output across a varying load, using either a single or multiple switch topology operating at constant frequency while maintaining high efficiency over the entire load range. This embodiment is especially suited to applications which require the sinusoidal voltage be held very close to a desired value in the presence of rapid changes in the conductance of the load, even in the sub-microsecond time domain as is common in computer applications and the like and in powering electronics equipment, especially a distributed system and especially a system wherein low voltage at high current is required. Embodiments and sub elements provide energy storage for low voltage, high current electronic loads, an ability to supply current with rapid time variation, connection of the energy storage element to the electronic load through specially configured conductors designed to minimize the created magnetic field around said conductors, providing extremely low inductance connections, permitting larger energy storage elements to be utilized, permitting energy storage to be located relatively remotely from the powered electronic load, and a steady voltage from a transformer isolated, high frequency ac to dc converter under varying load without the necessity for feedback control, among other aspects. The addition of capacitors which interact with the leakage inductance of the transformer to produce a natural regulation condition is used and the relationship between the value of the leakage inductance of the transformer and that of the added capacitances is different from the condition of resonance at the operating frequency.
Patent AU-3967189-A (AU)
Title: Imaging lidar system
Inventor: ULICH BOBBY LEE
IPC: G01S17/18
Filed: 1989-07-06
Abstract: A novel system for remote detection and imaging of underwater objects is presented. In accordance with the present invention, a laser is used to generate short pulses of light with pulse widths on the order of nanoseconds. The laser light is expanded by optics and projected down towards the surface of the water and to an object. Intensified CCD (charge coupled device) cameras (preferably two) are electronically shuttered after the time delay corresponding to the round trip propagation time and from to the object. This timing eliminates light scattered by the water from in front of and behind the object. As a result, the veiling luminance of the water is greatly attenuated and faint target signatures can be seen. The resulting gated images (displayed on a CRT) have sufficient spatial resolution to classify and/or identify the object. The imaging lidar system of the present invention takes advantage of the fact that all opaque targets will cast a shadow. The exposure of the two cameras in the system are timed such that one camera gives an image of the object against the backscattered light from the water while the other camera gives an image of the shadow of the object against the backscattered light. These two images are then subtracted to improve the detectability of the object.
Patent AU-4163393-A (AU)
Title: A motor system for an electric type vehicle
Inventor: JEANNERET RENE
IPC: H02P5/74
Filed: 1993-06-30
Abstract: The invention relates to a motor system of an electric vehicle comprising at least two asynchronous electric motors (M1, M2) supplied in parallel from a central electrical supply (2). This central electrical supply is managed by a control device (6) which provides it with a first control signal (SCF) determining the value of the supply frequency (FAL) and a second control signal (SCA) determining the value of the supply amplitude (UAL) of the supply voltage. These first and second control signals are adjusted essentially as a function of a signal (SMI) measuring the main supply current (IAL), a desired signal (SCS) and a signal (SFMX) representing the value of the maximum frequency of rotation of the rotors (R1, R2) belonging to the said motors. <IMAGE>
Patent AU-4177996-A (AU)
Title: New derivatives of pyroglutaminic acid, preparation process and applications
Inventor: CUADRADO SALOMON PEREZ
IPC: C07D401/06
Filed: 1995-12-15
Abstract: The new derivatives of pyroglutaminic acid have the formula (I) <CHEM> wherein R<1>, R<2> and R<3> are H or COR<4>, R<4> being lower alkyl or aryl, A<-> is Cl<-> CH3COO<-> and OH<-> and the ondulated line means that the substituent occupies any of the possible spatial positions. The process comprises the reaction of serine with pyridine and acetic anhydrid. These compounds may be applied in immunology as modifiers of the biological immune response, in the "integral" treatment of cancer and prevention of treatment of serious systemic infections in "high risk" patients suffering of chronical diseases and secondary immunodeficiency (cancer, AIDS, Diabetes Mellitus), or primary immunodeficiency (syndromes of DiGeorge, Down) <IMAGE>
Patent AU-4199593-A (AU)
Title: Ink-jet recording process, and ink set and ink-jet recording instrument for use in such process
Inventor: TAKIZAWA YOSHIHISA
IPC: C09D11/00
Filed: 1993-07-15
Abstract: Disclosed herein is an ink-jet recording process which comprises applying a first liquid at least containing a water-soluble resin having at least one carboxyl group or anhydride thereof, or sulfonic group in unit molecule to a recording medium and then applying an ink at least comprising water, an organic solvent, a dye, an alkali-soluble resin and an alkali to the portions where the first liquid has adhered, thereby forming an image. An ink set and an instrument for use in such a process are also disclosed.
Patent AU-4210199-A (AU)
Title: Tantalum sputtering target and method of manufacture
Inventor: ROSENBERG HARRY
IPC: C22C27/02
Filed: 1999-05-26
Abstract: Described is a method for producing high purity tantalum, the high purity tantalum so produced and sputtering targets of high purity tantalum. The method involves purifying starting materials followed by subsequent refining into high purity tantalum.
Patent AU-4403997-A (AU)
Title: Condensed N-acylindoles as antitumor agents
Inventor: DENNY WILLIAM ALEXANDER
IPC: A61K31/403
Filed: 1997-09-12
Abstract: The invention provides compounds of general formula (I), wherein: X is halogen or OSO2R, where R represents H or is unsubstituted or hydroxy- or amino-substituted lower alkyl; Y is a nitro or amine group or a substituted derivative thereof; W is selected from the structures of formulae (Ia, Ib or Ic), where E is -N= or -CH=, G is O, S, or NH, and Q is either up to three of R, OR, NRR, NO2, CONHR, NHCOR or NHCONHR, or is an additional group of formulae (Ia, Ib or Ic) and HET represents a 5- or 6-membered carbocycle or heterocycle; and A and B collectively represent a fused benzene or 2-CO2R pyrrole ring. In one embodiment, the group Y is an amine derivative substituted by a group which is a substrate for a nitroreductase or carboxypeptidase enzyme such that one of said enzymes is able to bring about removal of that group.
Patent AU-4407393-A (AU)
Title: Portable computer and docking station
Inventor: BOYLE DENNIS J
IPC: G06F1/16
Filed: 1993-06-04
Abstract: A first embodiment of the present invention comprises a fully functional portable computer with central processing unit, hard disk drive data storage, and liquid crystal display and a docking station having at least a floppy disk drive, video random access memory and video controller. A motorized docking/undocking mechanism automatically docks and undocks the portable computer and docking station after the user has inserted the portable computer into the docking station or after the user has requested that the units be undocked. Numerous mechanical and electrical safeguards prevent the docking or undocking of the units if such docking or undocking is likely to lead to the loss of data or damage to the components of either unit. The internal mechanical construction of the docking station allows the user to place a large cathode ray tube display monitor directly atop the docking station without hindering the docking or undocking of the portable computer.
Patent AU-4457285-A (AU)
Title: Process & apparatus for processing security paper webs or security paper sheets to form bundles
Inventor: KUHFUSS RUNWALT
IPC: B41F33/00
Filed: 1985-07-04
Abstract: Processing is based on print carriers in the form of security paper webs or security paper sheets, containing security paper prints which are arranged in the manner of matrices in transverse rows and longitudinal rows and on which spoilt notes are identified by a mark which can be read by a reading instrument. The print carriers pass, in succession, by a reading instrument which detects the positions of the spoilt notes and feeds them into a computer for storage, a cancellation printer controlled by this computer, which provides spoilt notes with a cancellation print, and a numbering machine. The numbering mechanisms of this numbering machine are moved forward by the computer in such a way that always the satisfactory security paper prints, placed in succession in any longitudinal row, are serially numbered, the spoilt notes being neglected. Subsequently, the print carries, having passed by another reading instrument, are cut up into individual security papers, the spoilt notes are separated out in a separation device and the remaining, serially numbered individual security papers are assembled to form bundles, each having a complete numerical sequence. In this way, correct and complete numerical sequence of the security papers contained in the automatically produced security paper bundles and security paper parcels is ensured, in spite of the separation of spoilt notes.
Patent AU-4644889-A (AU)
Title: Method of preventing or reducing eosinophilia
Inventor: COFFMAN ROBERT L
IPC: A61K39/395
Filed: 1989-11-01
Abstract: A method of preventing or reducing eosinophilia associated with certain immune disorders is provided. The method comprises administering an effective amount of an antagonist to human interleukin-5. Preferably, the antagonist is a blocking monoclonal antibody specific for human interleukin-5, or a fragment or binding composition derived therefrom.
Patent AU-4658399-A (AU)
Title: Method of inactivating viruses
Inventor: DUBBELMAN THOMAS MARINUS ALBER
IPC: A61K41/00
Filed: 1999-06-23
Abstract: The invention relates to a method of inactivating viruses in an erythrocytes-containing liquid with the use of light, wherein a sensitizer is added to the liquid. Further, an erythrocyte-binding agent is added to the liquid, which protects against the influence of singlet oxygen and/or radicals.
Patent AU-4844197-A (AU)
Title: Compensator to compensate for the changes in length caused by temperature effects
Inventor: FREYNHOFER ALBRECHT
IPC: B29C48/49
Filed: 1997-12-17
Abstract: Here is a new compensating elbow (11) to take up longitudinal thermal expansion and contraction. It is useful e.g. in fixed pipework carrying flowing products. The novel unit contains a piston (13) sliding in a block (14) and secured against rotation. The piston slides along a seat (17) which is sealed against the product. The passage (27) bends. At the inlet and outlet of the passage, there are flanges (28, 29). These are connections for fixed equipment (especially pipework).
Patent AU-4915990-A (AU)
Title: Method and apparatus for the measurement of the thermal conductivity of gases
Inventor: HACHEY RAYNALD
IPC: G01N27/18
Filed: 1990-02-06
Abstract: New methods and new katharometer apparatus for the measurement of thermal conductivity of gases are provided. The apparatus employs a single katharometer element (10), that is maintained at a constant operating temperature. If the element (10) temperature changes, changing its resistance, owing to passage of a gas with a different thermal characteristic, an amplifier (32) changes the power supplied to the katharometer element (10) to restore it to the predetermined temperature, the amplifier (32) output being a measure of the gas thermal conductivity. Operation of the apparatus is therefore independent of the resistance/temperature characteristic of the element (10) and is relatively insensitive to ambient temperature changes. Preferably a thermistor is employed as the katharometer element (10). Various operating circuits for the katharometer are disclosed. The invention also provides new operating methods for katharometers to reduce the sensitivity of measurement to thermal leakage and temperture changes to the katharometer body, and to permit the comparison of voltages across a series connected katharometer element (10) and a resistor (18) at a common reference point.
Patent AU-5039690-A (AU)
Title: Process for removing acid impurities from chlorofluorocarbons using carbon molecular sieves
Inventor: CHANG CHIN-HSIUNG
IPC: B01D53/02
Filed: 1990-01-03
Abstract: Chlorofluorocarbons are purified by removing hydrofluoric and hydrochloric acids with a carbon molecular sieve having an average pore size of about 3.5 Angstroms with no more than about 5% of the pores having a size less than 3.2 Angstroms and no more than about 5% of the pores having a size greater than 4.2 Angstroms.
Patent AU-5052290-A (AU)
Title: Sustained release bolus effective for the prolonged prevention, treatment or control of nematode, acarid and endo- and ectoparasitic infestations of ruminants
IPC: A23K20/00
Filed: 1990-02-26
Abstract: A sustained release bolus composition, containing a prophylactically effective amount of a compound selected from LL-F28249 alpha , 23-(O-methyloxime)LL-F28249 alpha  and derivatives thereof provides a method for protecting ruminant animals for a prolonged period of time against infestation by nematodes, acarids and endo- and ectoparasitic insects, and which over time can also eliminate the initial population of parasites present at treatment. The invention also relates to a method for the systemic control of ectoparasitic insect infestations of ruminant animals by orally administering to said animals a sustained release bolus containing an insecticidally effective amount of LL-F28249 alpha , 23-(O-methyloxime)LL-F28249 alpha  or derivative thereof, which continuously releases into the rumen of the treated animal a systemically effective amount of LL-F28249 alpha , 23-(O-methyloxime)LL-F28249 alpha  or derivative thereof.